A closer look at prostate MRI to avoid unnecessary biopsies
Part of Cancer, Kidney & urinary clinical trials.
This study uses repeat MRI scans to monitor men with an intermediate suspicion of prostate cancer, aiming to reduce unnecessary biopsies while still catching significant cancers early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are expected to live more than 10 more years.
- Your initial PSA level is below 20 ng/ml.
- Your doctor's rectal exam shows no signs of cancer outside the prostate.
- Your MRI result is PI-RADS 3 (uncertain) or PI-RADS 4 (suspicious) with a PSA density of 0.15 or lower.
- You must be willing and able to follow the study's check-up plan for up to four years.
- You have not had a prostate biopsy or been diagnosed with prostate cancer before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special type of MRI to look at suspicious spots in the prostate. It may help doctors decide if you need a biopsy or can safely avoid one.
This trial tests whether having repeated MRI scans can help find prostate cancer early in men who have never had a biopsy. It may be a good fit if you have a slightly elevated PSA and a suspicious spot on your first MRI.
This study is testing an approach to find prostate cancer earlier in men who may be at higher risk. If you fit the criteria, you may get an mpMRI scan before undergoing a prostate biopsy to check for cancer.
This study compares how well a doctor’s MRI reading (the PI-RADS score) and a computer AI tool detect prostate cancer. It may help improve how men get targeted biopsies and avoid missing important cancers.
This study tests a new MRI platform to better identify prostate issues before a biopsy. It is for people with elevated PSA whose doctor is considering a biopsy.
This study checks whether a detailed MRI method can help find prostate cancer earlier in people considered high risk. You may be asked to get an MRI and help the team see if it works well as a screening test.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.